06:32 AM EDT, 07/17/2024 (MT Newswires) -- Elevance Health ( ELV ) reported Q2 adjusted earnings Wednesday of $10.12 per diluted share, up from $9.04 a year earlier.

Analysts polled by Capital IQ expected $10.01.

Revenue for the quarter ended June 30 was $43.89 billion, compared with $43.67 billion a year earlier.

Analysts surveyed by Capital IQ expected $42.9 billion.

The company said it expects full-year 2024 adjusted earnings to be at least $37.20 per share. Analysts polled by Capital IQ expect $37.28.

The company also maintained a quarterly dividend of $1.63 per share, payable on Sept. 25 to shareholders of record on Sept. 10.

Price: 561.00, Change: +7.86, Percent Change: +1.42